Item 9 Labs Earns Five Podium Finishes at 710 Degree Cup
November 2nd, 2021
The Elevated Mainstream Cannabis Operator Won Two First Place Awards as well as Three More Podium Placements at Arizona’s Largest Cannabis Festival and Competition
PHOENIX, Nov. 2, 2021 /PRNewswire/ — Item 9 Labs, the elevated mainstream cannabis brand from Item 9 Labs Corp. (OTCQX: INLB), announced today that the brand took home five awards at the 710 Degree Cup—one of Arizona’s largest and longest-running annual cannabis festival and awards event—which was held October 16-17, 2021. Item 9 Labs won two first-place awards, two second-place awards and one third-place award for their high-quality vape and concentrate products.
- First place in the “Best Vape – Hybrid” category with the MAC Orion Live Resin Pod;
- First place in the “Best Concentrate – Sativa” category with MAC Lemon Live Badder;
- Second place in the “Best Vape – Indica” category with the Blueberry Orion Live Resin pod;
- Second place in the “Best Concentrate – Hybrid” category with MAC Live; and
- Third place in the “Best Vape – Sativa” category with the Mimosa Orion Live Resin pod.
Andrew Bowden, CEO of Item 9 Labs Corp. said, “We have been supporters and competitors in the 710 Degree Cup and its sister Errl Cup events since our inception. This only further advocates our dedication to providing premium products that help consumers find the best version of themselves.”
Item 9 Labs is no stranger to either competition, having won three additional first-place awards in the Errl Cup in early 2021 and a combined 8 top placements in 2019 and 2020. All told, Item 9 Labs has earned more than 20 podium placements for product excellence since 2019 across Arizona cannabis contests.
Created to promote dispensary accountability and patient appreciation, the 710 Degree Cup is organized by the Errl Cup and features entries from a majority of Arizona dispensaries and wholesalers. For the competition, Errl Cup staff visited local dispensaries and cannabis producers to secretly shop for concentrates. The decision for which product was purchased was based on each dispensary’s budtender’s choice for the shopper in reference to what type of strain was needed (Hybrid, Sativa or Indica).
Item 9 Labs was also recently recognized by Phoenix New Times as “Best of Phoenix – Best Special Media Branded Limited Edition Cannabis” for their Item 9 Labs and Phoenix New Times collaboration on the 50th Anniversary Special Edition Cartridge: 24k Gold Punch. This product is a true reserve Indica abounding in sweet and tangy flavor accompanied by earthy undertones and fruit punch notes.
For more information on Item 9 Labs, visit www.item9labs.com.
About Item 9 Labs
Item 9 Labs cultivates the highest quality cannabis products while providing transparency, consistency and well-being for an enhanced cannabis experience. With more than 20 podium finishes in Arizona marijuana competitions, Item 9 Labs is a trusted source for premium cannabis products. Starting with intentionally grown flower, the Item 9 Labs product catalogue spans 75-plus active cannabis strains and more than 150 differentiated cannabis vape products as well as premium concentrates and Apollo & Orion vape technologies. Currently, Item 9 Labs is the most in demand brand at more than 60% of Arizona’s dispensaries, according to LeafLink. For additional information, visit item9labs.com.
About Item 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: INLB) is a vertically integrated cannabis operator and dispensary franchisor delivering premium products from its large-scale cultivation and production facilities in the United States. The award-winning Item 9 Labs brand specializes in best-in-class products and user experience across several cannabis categories. The company also offers a unique dispensary franchise model through the national Unity Rd. retail brand. Easing barriers to entry, the franchise provides an opportunity for both new and existing dispensary owners to leverage the knowledge, resources, and ongoing support needed to thrive in their state compliantly and successfully. Item 9 Labs brings the best industry practices to markets nationwide through distinctive retail experience, cultivation capabilities, and product innovation. The veteran management team combines a diverse skill set with deep experience in the cannabis sector, franchising, and the capital markets to lead a new generation of public cannabis companies that provide transparency, consistency, and well-being. Headquartered in Arizona, the company is currently expanding its operations space up to 640,000+ square feet on its 50-acre site, one of the largest properties in Arizona zoned to grow and cultivate flower. For additional information, visit item9labscorp.com.
Item 9 Labs Corp.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.